Dr. Timothy Ryan, MD
NPI: 1760914717
Total Payments
$26,752
2024 Payments
$25,283
Companies
35
Transactions
154
Medicare Patients
831
Medicare Billing
$157,619
Payment Breakdown by Category
Other$18,940 (70.8%)
Travel$3,729 (13.9%)
Food & Beverage$3,555 (13.3%)
Consulting$466.67 (1.7%)
Education$62.11 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,940 | 9 | 70.8% |
| Travel and Lodging | $3,729 | 11 | 13.9% |
| Food and Beverage | $3,555 | 131 | 13.3% |
| Consulting Fee | $466.67 | 1 | 1.7% |
| Education | $62.11 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $9,775 | 16 | $0 (2024) |
| Neurelis, Inc. | $9,635 | 17 | $0 (2024) |
| UCB, Inc. | $5,166 | 48 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $466.67 | 1 | $0 (2024) |
| ARGENX US, INC. | $359.47 | 13 | $0 (2024) |
| ABBVIE INC. | $231.39 | 7 | $0 (2024) |
| LivaNova USA, Inc. | $158.91 | 2 | $0 (2024) |
| SK Life Science, Inc. | $107.74 | 5 | $0 (2024) |
| Lilly USA, LLC | $103.56 | 7 | $0 (2024) |
| GENZYME CORPORATION | $89.18 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,283 | 91 | Takeda Pharmaceuticals U.S.A., Inc. ($9,662) |
| 2023 | $1,076 | 47 | UCB, Inc. ($387.53) |
| 2022 | $261.94 | 14 | GENZYME CORPORATION ($64.92) |
| 2021 | $131.15 | 2 | AbbVie Inc. ($131.15) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $466.67 | General |
| 12/04/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Neurology | ||||||
| 12/02/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Neurology | ||||||
| 11/27/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,412.00 | General |
| Category: EPILEPSY | ||||||
| 11/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Neurology | ||||||
| 11/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Neurology | ||||||
| 11/14/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $141.52 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $95.14 | General |
| Category: EPILEPSY | ||||||
| 11/14/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $46.00 | General |
| Category: EPILEPSY | ||||||
| 11/12/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 11/11/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $115.73 | General |
| Category: EPILEPSY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Neurology | ||||||
| 10/14/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Neurology | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $547.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,695.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $972.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Travel and Lodging | In-kind items and services | $55.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $43.80 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 618 | 3,764 | $378,008 | $127,758 |
| 2022 | 8 | 213 | 258 | $96,084 | $29,861 |
Total Patients
831
Total Services
4,022
Medicare Billing
$157,619
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2323 | Injection, natalizumab, 1 mg | Office | 2023 | 11 | 3,001 | $105,000 | $57,164 | 54.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 83 | 83 | $35,690 | $11,446 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 103 | $22,660 | $9,428 | 41.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 71 | 113 | $39,550 | $7,968 | 20.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 78 | $16,146 | $6,965 | 43.1% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 27 | 41 | $32,800 | $6,335 | 19.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $11,165 | $3,465 | 31.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 12 | 12 | $8,640 | $3,401 | 39.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 79 | 79 | $14,220 | $3,360 | 23.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 50 | 77 | $17,325 | $2,584 | 14.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 15 | 15 | $12,750 | $2,177 | 17.1% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 23 | 23 | $9,200 | $2,121 | 23.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 19 | 19 | $9,900 | $1,993 | 20.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 11 | 11 | $12,650 | $1,970 | 15.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $4,500 | $1,761 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,940 | $1,444 | 29.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 14 | 14 | $7,000 | $1,412 | 20.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 12 | $6,120 | $1,155 | 18.9% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 12 | 12 | $4,560 | $949.20 | 20.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 14 | $3,192 | $661.64 | 20.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 53 | 53 | $22,790 | $8,740 | 38.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 45 | 74 | $25,900 | $5,667 | 21.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $7,700 | $3,019 | 39.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 11 | 11 | $7,380 | $2,917 | 39.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 13 | 13 | $13,390 | $2,510 | 18.7% |
About Dr. Timothy Ryan, MD
Dr. Timothy Ryan, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1760914717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Ryan, MD has received a total of $26,752 in payments from pharmaceutical and medical device companies, with $25,283 received in 2024. These payments were reported across 154 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,940).
As a Medicare-enrolled provider, Ryan has provided services to 831 Medicare beneficiaries, totaling 4,022 services with total Medicare billing of $157,619. Data is available for 2 years (2022–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Raleigh, NC
- Active Since 03/29/2017
- Last Updated 06/06/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760914717
Products in Payments
- HYQVIA (Biological) $9,662
- VALTOCO (Drug) $9,635
- Nayzilam (Drug) $4,431
- Briviact (Drug) $444.32
- VYVGART HYTRULO (Drug) $217.17
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $158.91
- UBRELVY (Drug) $150.75
- Fintepla (Drug) $133.16
- VYVGART (Drug) $116.52
- Rystiggo (Drug) $98.74
- AMYVID (Drug) $90.45
- ULTOMIRIS (Biological) $77.76
- AUBAGIO (Drug) $64.92
- QULIPTA (Drug) $61.82
- Aimovig (Biological) $51.54
- KESIMPTA (Drug) $50.94
- QUTENZA (Drug) $36.22
- AJOVY (Biological) $29.59
- APTIOM (Drug) $26.88
- RNS Neurostimulator Kit (Device) $25.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Raleigh
Aaron Lentz, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $239,027
Student in an Organized Health Care Education/Training Program $239,027
Laith Khoury, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $55,202
Student in an Organized Health Care Education/Training Program $55,202
Christopher Mcquinn, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $52,458
Student in an Organized Health Care Education/Training Program $52,458
Afreen Shariff, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $45,769
Student in an Organized Health Care Education/Training Program $45,769
Dr. Ryan Gentry, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $37,256
Student in an Organized Health Care Education/Training Program $37,256
Evan James, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,962
Student in an Organized Health Care Education/Training Program $20,962